Mpox strains are still mutating, further raising the risk of spread both in Africa and globally, Africa Centres for Disease ...

The Africa CDC said the vaccination deployment guide was created in anticipation of the vaccine delivery to the region.

The World Health Organisation and the Africa Centres for Disease Control and Prevention have committed to guiding the ...

The African continent is still in the acute phase of the Mpox outbreak as the number of cases reported so far this year ...

The spread of mpox has slowed down slightly across Africa but the epidemic is not over, the African Union's health watchdog ...

Africa’s primary public health body stated that it is requesting confirmation that US President-elect Donald Trump’s ...

The Access and Allocation Mechanism (AAM) for mpox has allocated an initial 899 000 vaccine doses for nine countries across ...

The trial will be conducted in the Democratic Republic of the Congo in partnership with Emergent BioSolutions.

The African continent has seen an increase of mpox cases of 545% in 2024, compared to last year, according to data released ...

Detailed price information for Emergent Biosolutions (EBS-N) from The Globe and Mail including charting and trades.

Africa's main public health body said it is seeking assurances that U.S. President-elect Donald Trump's administration will provide the funding and mpox vaccines promised by his predecessor.

More than 1,100 people have died of mpox in Africa, where some 48,000 cases have been recorded since January, according to the Centres for Disease Control and Prevention (Africa CDC).